e-SPACE Heart Failure 2023
Published: 25 October 2023
-
Views:
3135
-
Likes:
7
-
Views:
3135
-
Likes:
7
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF Ahmed Bennis, Frieder Braunschweig, Marco Metra, Alicia Chan, Ovidiu Chioncel, Stefan Anker
-
41m 37sPart 1 | Session 2 Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Patricia Campbell, Paul Kalra, Robert Mentz
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting Michael Böhm, Frieder Braunschweig, John JV McMurray, Gianluigi Savarese, Marianna Adamo
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM Brett Sperry, Arnt Kristen, Fabian Knebel, Ahmad Masri
-
44m 4sPart 1 | Session 5 Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Peter van der Meer, Daniela Tomasoni, Marianna Fontana
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice Stefan Anker, Clara Saldarriaga, Milton Packer, Shelley Zieroth, Muthiah Vaduganathan, Deepak L Bhatt
-
40m 4sPart 1 | Session 7 Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Giuseppe Rosano, Clara Saldarriaga, Gianluigi Savarese
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF Mikhail Kosiborod, Massimo Piepoli, Giulia Ferrannini, Wolfram Doehner, Mark Petrie
-
50m 39sPart 1 | Session 9 Special Live Interactive Session – Best practices for hyperkalemia management across the cardiorenal spectrum Giuseppe Rosano, Gianluigi Savarese, Ileana L Piña
-
56m 50sPart 1 | Session 10 Plenary session 5 – Worsening and acute heart failure Gerasimos Filippatos, Ileana L Piña, Marianna Adamo, Piotr Ponikowski, Javed Butler, John R Teerlink
-
36m 3sPart 2 | Session 1 Meet the expert – Iron deficiency and heart failure – what we have learnt so far? (Supported by an unrestricted educational grant from CSL Vifor) Ovidiu Chioncel, Piotr Ponikowski, Andrew Sindone
-
1h 1m 56sPart 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence Piotr Ponikowski, Yuhui Zhang, Ewa Jankowska, John GF Cleland, Stephan Von Haehling
-
25m 15sPart 2 | Session 3 Meet the expert – Practical approaches in the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Shelley Zieroth, Aaron Wong
-
59m 4sPart 2 | Session 4 Plenary session 7 – Managing comorbidities in HF Harriette Van Spall, Brenda Moura, Gerasimos Filippatos, Michael Böhm, João Pedro Ferreira
-
1h 46sPart 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place? Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, Marat Fudim, William T Abraham
-
44m 24sPart 2 | Session 6 Meet the expert – What happens if you fix FMR, but ignore the root cause of heart failure? (Supported by an unrestricted educational grant from Cardiac Dimensions) Stefan Anker, Javed Butler, Klaus Witte
-
1h 1m 52sPart 2 | Session 7 Plenary session 9 – New technologies for HF management John GF Cleland, Lynne W Stevenson, Jasper J Brugts, Dan Burkhoff
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Cecilia Bahit
Chief of Cardiology
Dr Cecilia Bahit is Chief of Cardiology at INECO Neurociencias Oroño, Santa Fe, AR. She is also currently serving as Co-Chair for the World Stroke Organization Heart & Brain Task Force.
Horst Sievert
Director
Dr Horst Sievert, MD, is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology, and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany.
Dr Sievert is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt. Dr Sievert became Director of the Department of Interventional Cardiology and Angiology of the Heart Center Rotenburg in 1990, Senior Consultant at the Bethanien Hospital in Frankfurt in 1993, and Director of the CardioVascular Center Frankfurt, Sankt Katharinen in 2003. He has been the principal investigator in a number of clinical trials and has authored more than 130 manuscripts and 500 abstracts in peer-reviewed journals and 50 books and book contributions.
Klaus Witte
Professor of Cardiology
Prof Klaus Witte is a Professor of Cardiology at the RWTH University Hospital Aachen, Aachen, DE and at the Leeds Institute of Cardiovascular & Metabolic Medicine, UK.
Paul Sorajja
Director of the Center for Valve and Structural Heart Disease
Dr Paul Sorajja is an Interventional Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, where he is the Director of the Center for Valve and Structural Heart Disease.
Dr Sorajja's clinical practice specialises in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the US for a patient with native mitral regurgitation in 2015, and has the highest worldwide experience with TMVR.
Dr Sorajja has published over 300 manuscripts and book chapters, with expertise in cardiac hemodynamics, clinical education, hypertrophic cardiomyopathy, and percutaneous therapy of structural heart disease.
Stephan Rosenkranz
Interventional Cardiologist
Prof Stephan Rosenkranz is an Interventional Cardiologist at Heart Center at the University of Cologne, Cologne, DE.
He has been involved in numerous clinical trials in the fields of atherosclerosis, heart failure and PH and has received numerous scientific awards.
Mitja Lainscak
Professor, Division of Cardiology
Prof Mitja Lainscak is a Professor in the Division of Cardiology at University of Ljubljana, Ljubljana, SI. He is also Director of the Slovenian Research Agency.
Comments